Company intelligence / Profile preview

Cylex

Columbia, Maryland, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Developed ImmuKnow, an FDA-cleared in vitro diagnostic assay for monitoring cellular immune function in immunosuppressed patients, particularly organ transplant recipients, to assess risk of rejection or infection.[1][2][3]

Therapeutic areas: ImmunologyInfectious Diseases
Industry: Metabolite Diagnostics

Partnerships

InGen BioSciences Group (exclusive distributor in France)

Beyond the preview

Go deeper on Cylex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cylex.

Explore the full profile